International urogynecology journal
Audio Summaries

A Dual-Task Deep-Learning Model with Fused Ultrasound Images for Simultaneous Typing and Grading of Cystocele

May 8, 2026

The authors aimed to develop and evaluate a dual-task deep-learning model, FD-Net, that utilizes fused 2D and 3D ultrasound images to automate the typing and grading of cystocele. Their results demonstrated that FD-Net outperformed single-modal models in diagnostic accuracy and F1-scores, suggesting its potential for clinical application in cystocele assessment.

Holistic Pelvic Floor: Pelvic Floor Stress Dysfunction Diseases

May 8, 2026

The authors aim to address the complexities of pelvic floor stress dysfunction diseases (PFSD) by advocating for a holistic approach to understanding and treating these conditions. They highlight the importance of recognizing the underlying biomechanical and etiological factors contributing to PFSD, suggesting a shift from symptom-focused treatments to those based on the mechanisms of the disease. The article discusses current advancements, challenges, and future directions in the management of PFSD.

The Effectiveness of PFMT in Treating Postpartum Urinary 1 Incontinence: A Systematic Review and Meta-analysis

May 7, 2026

This systematic review and meta-analysis aimed to evaluate the efficacy of pelvic floor muscle training (PFMT) in treating postpartum urinary incontinence (PPUI). The findings indicated that while PFMT significantly improved pelvic floor muscle strength and endurance, it did not show a significant impact on urinary incontinence incidence or quality of life. The authors concluded that although PFMT is beneficial for muscle function, its direct effect on symptom resolution remains uncertain due to data limitations and study heterogeneity.

Comparative Efficacy of Tadalafil and Amitriptyline in Female Interstitial Cystitis/Bladder Pain Syndrome: Double-Blind Randomized Trial

May 7, 2026

This study aimed to compare the efficacy and safety of tadalafil, amitriptyline, and their combination in treating female interstitial cystitis/bladder pain syndrome (IC/BPS). The results indicated that tadalafil, either alone or in combination with low-dose amitriptyline, significantly improved symptoms and urinary function compared to amitriptyline alone, suggesting it as a safe and effective treatment option for this condition.

Role of Ultrasound in the Evaluation of Women with Obstetric Anal Sphincter Injuries: Narrative Review

May 7, 2026

This narrative review investigates the role of ultrasound, specifically pelvic floor ultrasound (PFUS) and endoanal ultrasound (EAUS), in the follow-up and management of women with obstetric anal sphincter injuries (OASI). The authors aim to determine how these imaging techniques can assess the success of repairs, identify residual defects, and guide therapeutic decisions and counseling for future pregnancies. The findings suggest that PFUS is beneficial for evaluating OASI outcomes and informing subsequent care.

Beyond UTI: Chronic Lower Urinary Tract Symptoms as a Manifestation of Genitourinary Tuberculosis: Case Series with Review of Literature

May 7, 2026

The authors investigate the underdiagnosis of genitourinary tuberculosis (GUTB) as a cause of chronic lower urinary tract symptoms (LUTS) in women, particularly in TB-endemic regions. Through a case series of seven female patients, they highlight the clinical profiles, diagnostic challenges, and treatment outcomes, emphasizing the importance of urine AFB testing and imaging for timely diagnosis and management. The study concludes that GUTB should be considered in women with chronic LUTS, especially when traditional antibiotic treatments fail.

Toward a Future Where Diabetes No Longer Limits Mesh Surgery

May 7, 2026

The authors aim to address how diabetes impacts the outcomes of synthetic mesh implantation in urogynecologic pelvic reconstructive surgery, highlighting the need for improved perioperative glucose management tailored to individual patients. They emphasize the inadequacy of current predictive markers for mesh-related complications and advocate for a precision medicine approach that incorporates patient-specific factors, mechanistic studies, and biomarker discovery to enhance surgical outcomes.

Molecular Signatures of Bladder Pain Syndrome: A Systematic Review Towards Phenotype-Informed Diagnostics

May 5, 2026

The authors aim to synthesize molecular evidence related to bladder pain syndrome (BPS) and evaluate potential biomarkers for phenotype-informed diagnostics. Their systematic review identifies four inter-related mechanistic domains underlying BPS, highlighting the need for large, well-phenotyped studies to validate biomarkers and improve diagnostic and therapeutic strategies. The findings suggest that BPS consists of biologically distinct endotypes, emphasizing the importance of a more nuanced understanding of the condition.

Turkish Adaptation of Four Questionnaires for Patients with Overactive Bladder: The Overactive Bladder Questionnaire (OAB-Q), Urgency Questionnaire (UQ), Primary OAB Symptom Questionnaire (POSQ), and the Patient Perception of Bladder Condition (PPBC)

May 5, 2026

This study aimed to translate, culturally adapt, and assess the psychometric properties of four questionnaires for patients with overactive bladder (OAB) in Turkish: the OAB-Q, UQ, POSQ, and PPBC. The authors found that these instruments are valid, reliable, and culturally appropriate for evaluating OAB symptoms in Turkish-speaking populations, demonstrating strong internal consistency and test-retest reliability. The findings support their use in both clinical practice and research settings.

Effects of Different Cystoscopic Bladder Conditions on the Therapeutic Outcomes of Intravesical Platelet-Rich Plasma Injections in Patients with Interstitial Cystitis/Bladder Pain Syndrome

May 5, 2026

The authors aimed to evaluate the therapeutic outcomes of repeated intravesical platelet-rich plasma (PRP) injections in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) presenting with different cystoscopic bladder conditions. The study found that 50% of patients achieved treatment success, with notable improvements in bladder pain, capacity, and glomerulation grade, particularly in those with lower inflammation and higher baseline bladder capacity. These results suggest that intravesical PRP injections can be an effective treatment option for IC/BPS, especially in patients with specific bladder characteristics.